Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Round One for PQRI

Kurt Ullman  |  Issue: July 2009  |  July 1, 2009

 

Proof of Concept

Some of these problems are likely related to the newness of the effort, and some to resource allocation at CMS. “At this time, PQRI is really in the proof-of-concept stage, and no one thinks that this is its final form,” says Dr. Borenstein. “CMS is stuck with generating a system to implement the law but has not necessarily been given the resources to make it successful.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Even some rheumatologists who received bonuses were not sure they had covered the additional expenses incurred to comply with the initiative. “Our 12-person practice received about $8,000, and only three physicians qualified for payment,” says Dr. Baraf. “I doubt that covered the cost of paper and posting. We were very disappointed in the money for the amount of effort we put in.”

Dr. Flood agreed, noting that two-thirds of his bonus was used to cover compliance costs. In addition, much of the work done in one year must be repeated annually as the quality parameters and diseases covered expand. There do not appear to be many costs from last year to be amortized further this year.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

CMS acknowledged many of the concerns voiced here in their Physician Quality Reporting Initiative (PQRI): 2007 Reporting Experience publication, released in December 2008. Included in the report is a listing of the major reporting errors that should provide at least a general overview of what kinds of mistakes were being routinely made. CMS also outlined some changes they hope will improve access without impairing security.

Among all the concerns, there have been some positive things to come out of the first year of PQRI. “We think we are giving quality care all the time and most of us try our best,” says Dr. Borenstein. “Some fall through the cracks, or we forget to follow up on something. PQRI served to raise our consciousness and reminded us to ask the patient questions we may have assumed had already been addressed.”

PQRI Help

The ACR has developed an online resource, the Rheumatology Clinical Registry, that can assist with claims-based reporting for PQRI. To learn more about PQRI, see the PQRI Update on page 10 of this issue. To learn more about the RCR, visit www.rheumatology.org/rcr.

Participants Ambivalent About Continuing

The physicians interviewed were, at best, ambivalent about continuing the program. “If I wasn’t involved with ACR, I think I would be very cautious about investing staff time and effort to PQRI,” says Dr. Kolba. “If this was my first time, I would be reluctant and probably tell others to let it go through additional iterations before committing time to it. I want to make sure that others are happy with the program before going in again.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Centers for Medicare & Medicaid Services (CMS)DEXA scanMedicarePQRIPractice

Related Articles

    Practice Page: What PQRI Means to Rheumatologists

    November 1, 2010

    The Physician Quality Reporting Initiative (PRQI) is a voluntary quality reporting program initiated by the Centers for Medicare and Medicaid Services (CMS) in 2007. CMS provides bonus payments to eligible providers who successfully report on applicable PQRI measures. For 2010, rheumatologists who successfully participate in PQRI can earn an incentive payment of 2% of the…

    Practical Advice for the Rheumatologist on Medicare PQRI

    July 1, 2009

    It is not too late to participate in the Centers for Medicare & Medicaid Services’ (CMS) 2009 Physician Quality Reporting Initiative (PRQI). Participation is voluntary, but providers who participate now will better prepare themselves for probable future reporting requirements while qualifying for an incentive payment from CMS.

    The Quality Movement Explained

    July 1, 2007

    “To Err is Human,” published by the Institute of Medicine in 1999, set off a firestorm of quality initiatives when it announced that at least 44,000 to 98,000 people die in hospitals every year because of medical errors. The first quality initiatives, which were aimed at hospitals, have now trickled down to physician practices. For two years there have been reports of payors moving to a pay-for-performance system or value-based purchasing.

    PQRI Now Includes RA Measures Group

    May 1, 2009

    In 2008, the only Physician Quality Reporting Initiative (PQRI) measure that applied to rheumatoid arthritis (RA) was disease-modifying antirheumatic drug therapy. For 2009, five new RA measures were included, for a total of six measures in the new RA Measures Group. The five new measures were developed in 2008 by the National Committee for Quality Assurance in collaboration with the ACR and the American Medical Association’s Physician Consortium for Performance Improvement and were subsequently adopted by Medicare.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences